You limited your search to:

 Collection: Congressional Research Service Reports
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: September 10, 2001
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: October 3, 2002
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: January 3, 2003
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: June 11, 2003
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: March 10, 2004
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Prescription Drug User Fee Act of 1992: Effects on Bringing New Drugs to Market

Prescription Drug User Fee Act of 1992: Effects on Bringing New Drugs to Market

Date: September 12, 1997
Creator: Cantor, David J
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes

The Hatch-Waxman Act: Proposed Legislative Changes

Date: September 3, 2002
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: November 25, 2002
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: January 16, 2003
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: April 2, 2003
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department